GlucoSentient

About:

GlucoSentient, a healthcare technology company, develops a personal glucose meter that allows diabetics to detect food contaminants.

Website: http://glucosentient.com/

Top Investors: National Science Foundation, Serra Ventures

Description:

GlucoSentient, Inc. develops personal glucose meters for diabetes patients around the globe. The company offers its products for therapeutic drug and heart health monitoring applications. It also offers test strips for detecting trace amounts of contaminates, such as bacteria, viruses, or chemical contamination in food. GlucoSentient, Inc. was incorporated in 2011 and is based in Champaign, Illinois.

Total Funding Amount:

$1.14M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Champaign, Illinois, United States

Founded Date:

2011-01-01

Founders:

N. Y. Wong, Yi Lu

Number of Employees:

1-10

Last Funding Date:

2013-09-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai